Boothbay Fund Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Boothbay Fund Management’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-71,500	Closed	-$429K	–	2610
2022 Q3	$429K	Buy	+71,500	New	+$406K	0.01%	1311

Boothbay Fund Management's STSA Position: Q2 2023 in Review

Boothbay Fund Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 11,968 shares — an estimated $8.36K sold.

Boothbay Fund Management first reported a position in STSA in Q2 2020 and held it in 10 quarters. The position peaked at $815K in Q2 2020. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Boothbay Fund Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 11,968 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $8.36K.
Boothbay Fund Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Boothbay Fund Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $815K in Q2 2020.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.